Pub. Date : 2021 Jun 15
PMID : 33832946
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Phase 1 trial of N-803, an IL-15 receptor agonist, with rituximab in patients with indolent non-Hodgkin lymphoma. | n-803 | interleukin 15 | Homo sapiens |
| 2 | PURPOSE: N-803 is an IL-15 receptor superagonist complex, designed to optimize in vivo persistence and trans-presentation, thereby activating and expanding natural killer (NK) cells and CD8+ T cells. | n-803 | interleukin 15 | Homo sapiens |